Analystreport

Adaptive Biotechnologies Co. (NASDAQ: ADPT) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $54.00 to $21.00. They now have a "neutra

Adaptive Biotechnologies Corporation  (ADPT) 
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: adhc.com